PLoS ONE (Jan 2024)

Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.

  • Takahiro WakasakiI,
  • Tomomi Manako,
  • Ryuji YasumatsuI,
  • Hirotaka Hara,
  • Satoshi Toh,
  • Muneyuki Masuda,
  • Moriyasu YamauchiID,
  • Yuichiro Kuratomi,
  • Emi Nishimura,
  • Toranoshin Takeuchi,
  • Mioko Matsuo,
  • Rina Jiromaru,
  • Kazuki Hashimoto,
  • Noritaka Komune,
  • Takashi Nakagawa

DOI
https://doi.org/10.1371/journal.pone.0303720
Journal volume & issue
Vol. 19, no. 5
p. e0303720

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0271907.].